Literature DB >> 9529119

Granulocytic ehrlichiosis in tick-immune guinea pigs.

S Das1, K Deponte, N L Marcantonio, J W Ijdo, E Hodzic, P Katavolos, S W Barthold, S R Telford, F S Kantor, E Fikrig.   

Abstract

We investigated whether Ixodes scapularis-mediated host immunity interrupts transmission of the agent of human granulocytic ehrlichiosis (aoHGE) to guinea pigs. Ticks infected with aoHGE readily transmitted aoHGE to tick-immune guinea pigs, despite incomplete tick engorgement and host attachment. Although tick immunity can prevent Lyme borreliosis, protection is not afforded against granulocytic ehrlichiosis.

Entities:  

Mesh：

Year:  1998        PMID： 9529119      PMCID： PMC108126     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

1.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Cross-resistance between instars of the brown ear-tick Rhipicephalus appendiculatus (Acarina: Ixodidae).

Authors:  B H Fivaz; S Tucker; T Petney
Journal:  Exp Appl Acarol       Date:  1991-08       Impact factor: 2.132

Review 3.  Host immunity to ticks.

Authors:  S K Wikel
Journal:  Annu Rev Entomol       Date:  1996       Impact factor: 19.686

4.  Infestation with pathogen-free nymphs of the tick Ixodes scapularis induces host resistance to transmission of Borrelia burgdorferi by ticks.

Authors:  S K Wikel; R N Ramachandra; D K Bergman; T R Burkot; J Piesman
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Transmission of Theileria parva bovis (Boleni strain) to cattle resistant to the brown ear tick Rhipicephalus appendiculatus (Neumann).

Authors:  B H Fivaz; R A Norval; J A Lawrence
Journal:  Trop Anim Health Prod       Date:  1989-05       Impact factor: 1.559

6.  Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera.

Authors:  L A Magnarelli; J S Dumler; J F Anderson; R C Johnson; E Fikrig
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Acquired resistance in dogs to repeated infestation with Ixodes scapularis (Acari: Ixodidae) reduces tick viability and reproductive success.

Authors:  J A Gebbia; E M Bosler; R D Evans; E M Schneider
Journal:  Exp Appl Acarol       Date:  1995-10       Impact factor: 2.132

8.  Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence.

Authors:  J S Dumler; J S Bakken
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

9.  Clethrionomys glareolus, but not Apodemus flavicollis, acquires resistance to Ixodes ricinus L., the main European vector of Borrelia burgdorferi.

Authors:  A Dizij; K Kurtenbach
Journal:  Parasite Immunol       Date:  1995-04       Impact factor: 2.280

10.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307
View more
  3 in total

1.  Effect of prior exposure to noninfected ticks on susceptibility of mice to Lyme disease spirochetes.

Authors:  D Richter; A Spielman; F R Matuschka
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

2.  Specific expression of Anaplasma marginale major surface protein 2 salivary gland variants occurs in the midgut and is an early event during tick transmission.

Authors:  Christiane V Löhr; Fred R Rurangirwa; Terry F McElwain; David Stiller; Guy H Palmer
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila.

Authors:  M L Levin; D Fish
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.